Correction to: Percutaneous Therapy for Tricuspid Regurgitation: A New Frontier for Interventional Cardiology
In the editorial by Kapadia et al, “Percutaneous Therapy for Tricuspid Regurgitation: A New Frontier for Interventional Cardiology,” which published online ahead of print March 23, 2017 (Circulation. 2017;135 [e-pub ahead of print]. DOI: 10.1161/CIRCULATIONAHA.116.026533), a correction is needed. The following statement was made in error:
“This patient population is obviously very sick and suffered a 90% mortality at 9-months, despite only 5% in hospital mortality. With such poor survival, no observations can be made with regards to “long-term” clinical or echocardiographic outcomes.”
It should read as follows:
“This is a highly comorbid patient population, and the authors are commended on the low in-hospital mortality of 5%. However, without longer-term clinical or echocardiographic follow-up, observations regarding durability of repair and its impact on clinical outcomes cannot be made.”
The correction has been made to the print version and the current online version of the article, which is available at http://circ.ahajournals.org/content/early/2017/03/22/CIRCULATIONAHA.116.026533.
Circulation is available at http://circ.ahajournals.org.
- © 2017 American Heart Association, Inc.